港股异动 | 金斯瑞生物科技(01548)涨超3% CARVYKTI第三季度产生贸易销售净额约5.24亿美元

Group 1 - Kingsray Biotechnology (01548) saw a stock increase of over 3%, currently trading at 16.27 HKD with a transaction volume of 32.066 million HKD [1] - On October 14, Kingsray Biotechnology announced that, according to the collaboration and licensing agreement established with Janssen Biotech, Inc. on December 21, 2017, CARVYKTI® is expected to generate net trade sales of approximately 524 million USD for the quarter ending September 30, 2025 [1]